Rhys Brady

Dr. Rhys Brady


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Neurobiology of Disease
Verified
Journal Article
Closed access
RBRhys Brady
Rhys Brady
PCPablo Miguel Casillas-Espinosa
Pablo Miguel Casillas-Espinosa
DADenes V. Agoston
Denes V. Agoston
EBEdward H. Bertram
Edward H. Bertram
AKAlaa Kamnaksh
Alaa Kamnaksh
SSSandy R. Shultz
Sandy R. Shultz

9 December 2020 in Bone Research
Verified
Journal Article
Open access
PDF file
KWKer Rui Wong
Ker Rui Wong
RMRichelle Mychasiuk
Richelle Mychasiuk
TOTerence J. O’bRien
Terence J. O’bRien
SSSandy R. Shultz
Sandy R. Shultz
SMStuart J. McDonald
Stuart J. McDonald
RBRhys Brady
Rhys Brady
Neurological heterotopic ossification (NHO) is a debilitating condition where bone forms in soft tissue, such as muscle surrounding the hip and knee, following an injury to the brain or spinal cord. This abnormal formation of bone can result in nerve impingement, pain, contractures and impaired movement. Patients are often diagnosed with NHO after the bone tissue has completely mineralised, leaving invasive surgical resection the only remaining treatment option. Surgical resection of NHO creates potential for added complications, particularly in patients with concomitant injury to the central nervous system (CNS). Although recent work has begun to shed light on the physiological mechanisms involved in NHO, there remains a significant knowledge gap related to the prognostic biomarkers and prophylactic treatments which are necessary to prevent NHO and optimise patient outcomes. This article reviews the current understanding pertaining to NHO epidemiology, pathobiology, biomarkers and treatment options. In particular, we focus on how concomitant CNS injury may drive ectopic bone formation and discuss considerations for treating polytrauma patients with NHO. We conclude that understanding of the pathogenesis of NHO is rapidly advancing, and as such, there is the strong potential for future research to unearth methods capable of identifying patients likely to develop NHO, and targeted treatments to prevent its manifestation.

1 July 2021 in Experimental Neurology
Verified
Journal Article
Closed access
WOWilliam T. O'BRien
William T. O'BRien
LPLouise Pham
Louise Pham
RBRhys Brady
Rhys Brady
JBJesse Bain
Jesse Bain
GYGlenn R. Yamakawa
Glenn R. Yamakawa
SMStuart J. McDonald
Stuart J. McDonald

1 April 2020 in Bone
Verified
Journal Article
Closed access
RBRhys Brady
Rhys Brady
MZMichael Z. Zhao
Michael Z. Zhao
KWKer R. Wong
Ker R. Wong
PCPablo M. Casilla-Espinosa
Pablo M. Casilla-Espinosa
GYGlenn R. Yamakawa
Glenn R. Yamakawa
SSSandy R. Shultz
Sandy R. Shultz

1 January 2021 in Biomarker Insights
Verified
Journal Article
Open access
PDF file
KWKer Rui Wong
Ker Rui Wong
WOWilliam T O’BRien
William T O’BRien
MSMujun Sun
Mujun Sun
GYGlenn Yamakawa
Glenn Yamakawa
TOTerence J O’BRien
Terence J O’BRien
RBRhys Brady
Rhys Brady
Introduction: Serum neurofilament light (NfL) is an emerging biomarker of traumatic brain injury (TBI). However, the effect of peripheral injuries such as long bone fracture and skeletal muscle injury on serum NfL levels is unknown. Therefore, the aim of this study was to determine whether serum NfL levels can be used as a biomarker of TBI in the presence of concomitant peripheral injuries. Methods: Rats were randomly assigned to one of four injury groups: polytrauma (muscle crush + fracture + TBI; n = 11); peripheral injuries (muscle crush + fracture + sham-TBI; n = 12); TBI-only (sham-muscle crush + sham-fracture + TBI; n = 13); and triple-sham (n = 7). At 2-days post-injury, serum levels of NfL were quantified using a Simoa HD-X Analyzer. Results: Compared to triple-sham rats, serum NfL concentrations were higher in rats with peripheral injuries-only, TBI-only, and polytrauma. When compared to peripheral injury-only rats, serum NfL levels were higher in TBI-only and polytrauma rats. No differences were found between TBI-only and polytrauma rats. Conclusion: Serum NfL levels did not differ between TBI-only and polytrauma rats, indicating that significant peripheral injuries did not affect the sensitivity and specificity of serum NfL as a biomarker of moderate TBI. However, the finding of elevated serum NfL levels in rats with peripheral injuries in the absence of a TBI suggests that the presence of such injuries may limit the utility of NfL as a biomarker of less severe TBI (eg, concussion).

1 January 2021 in Cerebral Cortex Communications
Verified
Journal Article
Open access
PDF file
SSSabrina Salberg
Sabrina Salberg
GYGlenn R Yamakawa
Glenn R Yamakawa
YGYannick Griep
Yannick Griep
JBJesse Bain
Jesse Bain
JBJaimie Beveridge
Jaimie Beveridge
RMRichelle Mychasiuk
Richelle Mychasiuk
Although adverse early experiences prime individuals to be at increased risk for chronic pain, little research has examined the trauma–pain relationship in early life or the underlying mechanisms that drive pathology over time. Given that early experiences can potentiate the nociceptive response, this study aimed to examine the effects of a high-fat, high-sugar (HFHS) diet and early life stress (maternal separation [MS]) on pain outcomes in male and female adolescent rats. Half of the rats also underwent a plantar-incision surgery to investigate how the pain system responded to a mildly painful stimuli in adolescence. Compared with controls, animals that were on the HFHS diet, experienced MS, or had exposure to both, exhibited increased anxiety-like behavior and altered thermal and mechanical nociception at baseline and following the surgery. Advanced magnetic resonance imaging demonstrated that the HFHS diet and MS altered the maturation of the brain, leading to changes in brain volume and diffusivity within the anterior cingulate, amygdala, corpus callosum, nucleus accumbens, and thalamus, while also modifying the integrity of the corticospinal tracts. The effects of MS and HFHS diet were often cumulative, producing exacerbated pain sensitivity and increased neurobiological change. As early experiences are modifiable, understanding their role in pain may provide targets for early intervention/prevention.